Evotec SE Sponsored ADR EVO

Healthcare Biotechnology

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

NDAQ:EVO - Post by User

Evotec SE Sponsored ADR

<< Previous

Bullboard Posts

Post by whytestockson Nov 14, 2024 4:31pm

32 Views

Post# 36313598

Halozyme Confirms Proposal to Combine with Evotec for Euro11

Just In: $EVO Halozyme Confirms Proposal to Combine with Evotec for Euro11.00 Per Share in an All-Cash TransactionHalozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction PR Newswire Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team...EVO - Halozyme Confirms Proposal to Combine with Evotec for Euro11.00 Per Share in an All-Cash Transaction

<< Previous

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide